Frizzled Receptors as Potential Therapeutic Targets in Human Cancers
Chui-Mian Zeng1, Zhe Chen2, Li Fu3
1Guangdong Key Laboratory for Genome Stability & Disease Prevention, Department of Pharmacology and Carson International Cancer Research Centre, Shenzhen University School of Medicine, Shenzhen 518060, China. 2160220126@email.szu.edu.cn.
Abstract:
Frizzled receptors (FZDs) are a family of seven-span transmembrane receptors with hallmarks of G protein-coupled receptors (GPCRs) that serve as receptors for secreted Wingless-type (WNT) ligands in the WNT signaling pathway. Functionally, FZDs play crucial roles in regulating cell polarity, embryonic development, cell proliferation, formation of neural synapses, and many other processes in developing and adult organisms. In this review, we will introduce the basic structural features and review the biological function and mechanism of FZDs in the progression of human cancers, followed by an analysis of clinical relevance and therapeutic potential of FZDs. We will focus on the development of antibody-based and small molecule inhibitor-based therapeutic strategies by targeting FZDs for human cancers.
Insights
Frizzled receptors (FZDs), key in WNT signaling, are crucial for cell functions and cancer progression. This review explores FZD roles in cancer and their therapeutic potential using targeted inhibitors and antibodies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Frizzled receptors (FZDs) are transmembrane receptors essential for WNT signaling.
- FZDs regulate critical cellular processes including development, polarity, and proliferation.
- Dysregulation of FZDs is implicated in various human cancers.
Purpose of the Study:
- To review the structural features, biological functions, and mechanisms of FZDs in human cancer progression.
- To analyze the clinical relevance and therapeutic potential of targeting FZDs in oncology.
- To focus on developing antibody-based and small molecule inhibitor-based strategies against FZDs for cancer treatment.
Main Methods:
- Literature review of FZD structure and function.
- Analysis of FZD roles in cancer cell biology and signaling pathways.
- Review of current and emerging therapeutic strategies targeting FZDs.
Main Results:
- FZDs are integral to WNT pathway activation, influencing cell fate and behavior.
- Aberrant FZD signaling contributes to tumorigenesis, metastasis, and drug resistance.
- Targeting FZDs shows promise for novel cancer therapies.
Conclusions:
- FZDs represent significant targets for cancer therapy due to their roles in WNT signaling and cancer progression.
- Therapeutic strategies involving antibodies and small molecule inhibitors offer potential for effective cancer treatment by modulating FZD activity.
More Related Videos
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Internal Receptors
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
